Saltar al contenido
Merck

Tumor Protein (TP)-p53 Members as Regulators of Autophagy in Tumor Cells upon Marine Drug Exposure.

Marine drugs (2016-08-19)
Edward A Ratovitski
RESUMEN

Targeting autophagic pathways might play a critical role in designing novel chemotherapeutic approaches in the treatment of human cancers, and the prevention of tumor-derived chemoresistance. Marine compounds were found to decrease tumor cell growth in vitro and in vivo. Some of them were shown to induce autophagic flux in tumor cells. In this study, we observed that the selected marine life-derived compounds (Chromomycin A2, Psammaplin A, and Ilimaquinone) induce expression of several autophagic signaling intermediates in human squamous cell carcinoma, glioblastoma, and colorectal carcinoma cells in vitro through a transcriptional regulation by tumor protein (TP)-p53 family members. These conclusions were supported by specific qPCR expression analysis, luciferase reporter promoter assay, and chromatin immunoprecipitation of promoter sequences bound to the TP53 family proteins, and silencing of the TP53 members in tumor cells.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo de cabra anti-IgG de conejo (cadenas pesadas + ligeras), conjugado con HRP, 1 mg/mL, Chemicon®
Sigma-Aldrich
Anticuerpo de cabra anti-IgG de ratón, conjugado con HRP, especie adsorbida, 0.8 mg/mL, Chemicon®
Sigma-Aldrich
Anticuerpo de burro anti-IgG de cabra, conjugado con HRP, especie adsorbida, Chemicon®, from donkey